This preoperative cutoff of AFP > 1000 ng/mL was adopted by the US allocation criteria in 2017, except under region-based protocols, such as the Region 5 down-staging for “all comers” with HCC [42,43]. The gene discussed is AFP; the disease is hepatocellular carcinoma.